Cellectar biosciences, inc. (CLRB)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss

-3,957

-3,379

-3,903

-3,187

-3,621

-3,827

-3,014

-2,920

-3,475

-4,078

-3,470

-3,121

-2,891

-2,585

-2,286

-2,132

824

950

-1,858

-2,286

-2,301

-3,346

324

-2,085

-2,943

-3,948

-1,315

-2,064

-3,453

-2,157

-2,052

-2,230

-2,356

Adjustments to reconcile net loss to cash used in operating activities:
Depreciation and amortization

33

32

33

33

32

32

15

16

17

1,251

105

101

86

87

87

90

90

90

90

90

90

89

89

92

96

99

105

108

111

113

118

126

139

Stock-based compensation expense

144

207

149

301

207

208

163

175

173

185

176

231

165

132

174

119

102

18

165

71

191

167

146

273

262

1,221

297

377

425

343

336

406

417

Non cash lease Expense

15

15

14

13

13

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Non-cash interest expense related to convertible debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

375

31

19

-

-

-

-

-

-

-

-

Intrinsic value of beneficial conversion feature associated with convertible debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

Non-cash interest expense related to convertible debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

Issuance of stock for technology and services

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

Impairment of intangible assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

Loss on disposal of fixed assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0

0

0

-0

0

-0

0

-2

-3

0

0

-4

0

0

0

0

Loss on revaluation of derivative warrants

0

0

46

1

-4

43

66

-20

-26

5

9

90

-82

60

177

198

2,824

3,141

233

4

288

-1,083

2,850

573

-54

110

1,597

660

6

-

-

-

-

(Gain) loss on revaluation of derivative warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-28

Loss on issuance of derivative warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-744

0

0

0

0

Changes in:
Prepaid expenses and other current assets

0

-201

-361

729

-36

-44

464

-82

-107

-441

-102

63

199

255

275

-11

-55

-86

197

-52

-49

-69

127

-49

-82

-50

181

-44

-135

-8

196

-44

-71

Other assets

0

-

-

-465

-11

-138

40

129

49

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Lease liability

-25

-24

-23

-545

511

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accounts payable and accrued liabilities

277

-211

347

995

-10

-962

477

209

16

-151

552

280

-230

328

270

208

-67

96

-132

-112

-109

-205

-55

203

-169

4

135

158

145

4

104

136

-6

Accrued interest

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

Deferred rent

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2

2

2

2

2

Other assets and liabilities

-

-

-

-

-

-

-

-

-

-

1

1

1

-

6

0

0

-

-0

-0

-0

-

-1

-1

-1

-

-

-

-

-

-

-

-

Cash used in operating activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-1,901

-1,818

-1,494

-2,165

-2,187

-2,366

-2,141

-2,096

-2,007

-2,594

-2,678

-2,553

-2,033

-1,888

-

-

-

-

Cash used in operating activities

-3,512

-2,681

-3,544

-2,652

-2,815

-2,743

-2,968

-2,545

-3,184

-2,826

-2,543

-2,663

-2,987

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-1,690

-1,497

-1,702

CASH FLOWS FROM INVESTING ACTIVITIES:
Cash acquired in a business combination

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

Purchases of fixed assets

10

5

3

9

6

383

0

0

1

0

26

254

66

66

1

4

0

18

6

8

25

12

2

0

15

12

41

0

92

60

8

13

15

Proceeds from sale of fixed assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

Purchases of short-term certificates of deposit

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

Proceeds from short-term certificates of deposit

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

Change in restricted cash

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-1,878

-0

-121

2,000

0

0

0

Payment for intangible assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

Cash used in investing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-4

0

-18

-6

-8

-25

-12

-2

0

-15

-12

1,836

0

28

-

-

-

-

Cash used in investing activities

-10

-5

-3

-9

-6

-373

45

0

-1

0

-26

-254

-66

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-8

-13

-15

CASH FLOWS FROM FINANCING ACTIVITIES:
Payments on capital lease obligations.

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cash paid for issuance costs

-

-

-

-

-

-

-

-

-

-

-

-

-

176

0

81

69

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from issuance of warrants

-

-

-

-

-

-

-

-

-

-

-

-

2,934

0

0

652

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cash paid for issuance costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Reverse stock split fractional shares

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from issuance of convertible notes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

4,000

0

0

0

0

0

0

0

0

Payments on notes payable

-

-

-

-

-

-

-

-

-

-

0

0

86

-

60

60

60

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from issuance of common stock, net of underwriting issuance costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

4,975

1,967

0

4,870

0

Payments on capital lease obligations

-

-

-

-

-

-

-

0

0

0

0

0

0

0

0

0

0

0

0

0

1

0

0

0

0

0

0

0

0

0

0

0

0

Proceeds from conversion of warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

937

150

0

0

Proceeds from long-term obligations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

Payments on long-term obligations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

60

59

0

0

-

-

-

-

-

-

-

0

0

0

0

0

Repurchase of common stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

Cash in lieu of fractional shares in a business combination

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

Change in deferred issuance costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

70

-70

0

0

0

Cash provided by financing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

7,919

-131

2,898

-189

-0

-1

0

12,049

-174

3,999

-0

-0

-0

5,045

-

-

-

-

Cash (used in) provided by financing activities

0

0

-0

9,023

-0

-0

15,116

-93

-0

7,170

-81

-7

2,847

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

150

4,870

-0

NET DECREASE IN CASH, CASH EQUIVALENTS, AND RESTRICTED CASH

-3,522

-2,686

-3,548

6,361

-2,822

-3,117

12,192

-2,639

-3,186

4,344

-2,650

-2,925

-206

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

INCREASE (DECREASE) IN CASH, CASH EQUIVALENTS, AND RESTRICTED CASH

-

-

-

-

-

-

-

-

-

-

-

-

-

5,798

-2,276

6,013

-1,949

1,385

-2,360

-2,196

-2,393

-2,153

9,949

-2,181

1,389

-2,692

-717

-2,034

3,184

-920

-1,548

3,358

-1,718

SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION
Cash paid for interest expense

1

-1

1

0

0

0

0

0

0

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Obtaining a right-of-use asset in exchange for a lease liability

0

-

0

0

405

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Lease liability established through right-of-use asset

0

-

0

0

609

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Fair value of derivative warrants issued

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

5,720

0

0

0

0

Relative fair value of warrants issued with debentures

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

254

0

0

0

0

-

-

-

-

Cash paid for interest expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1

1

1

21

22

0

-

-

-

-

-

-

-

0

-43

0

43

0

Fair value of derivative warrants reclassified to equity upon cashless exercise

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

43

0

-19

19

Issuance of common stock in connection with the conversion of notes payable and $463,722 in accrued interest

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

Fair value of assets acquired in exchange for securities in a business combination

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

Reclassification to equity for warrants that are no longer derivative instruments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

Goodwill resulting from business combination

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0